These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study. Sonnet E, Lacut K, Roudaut N, Mottier D, Kerlan V, Oger E. Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women. Aedo AR, Landgren BM, Diczfalusy E. Maturitas; 1990 Nov; 12(4):333-43. PubMed ID: 2124648 [Abstract] [Full Text] [Related]
14. Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Oh H, Arem H, Matthews CE, Wentzensen N, Reding KW, Brinton LA, Anderson GL, Coburn SB, Cauley JA, Chen C, Goodman D, Pfeiffer RM, Falk RT, Xu X, Trabert B. Br J Cancer; 2017 Sep 26; 117(7):1070-1078. PubMed ID: 28817836 [Abstract] [Full Text] [Related]
15. Individualised vs fixed dose of oral 17β-oestradiol for induction of puberty in girls with Turner syndrome: an open-randomised parallel trial. Labarta JI, Moreno ML, López-Siguero JP, Luzuriaga C, Rica I, Sánchez-del Pozo J, Gracia-Bouthelier R, Spanish Turner working group. Eur J Endocrinol; 2012 Oct 26; 167(4):523-9. PubMed ID: 22807477 [Abstract] [Full Text] [Related]
16. Metabolic effects of oestrogens: impact of the route of administration. Ho KK, O'Sullivan AJ, Wolthers T, Leung KC. Ann Endocrinol (Paris); 2003 Apr 26; 64(2):170-7. PubMed ID: 12773957 [Abstract] [Full Text] [Related]
17. A physiological mode of puberty induction in hypogonadal girls by low dose transdermal 17 beta-oestradiol. Illig R, DeCampo C, Lang-Muritano MR, Prader A, Torresani T, Werder EA, Willi U, Schenkel L. Eur J Pediatr; 1990 Dec 26; 150(2):86-91. PubMed ID: 2126236 [Abstract] [Full Text] [Related]
18. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17 beta. Lyrenäs S, Carlström K, Bäckström T, von Schoultz B. Br J Obstet Gynaecol; 1981 Feb 26; 88(2):181-7. PubMed ID: 7459307 [Abstract] [Full Text] [Related]
19. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration. Dick IM, Prince RL, Kelly JJ, Ho KK. Clin Endocrinol (Oxf); 1995 Aug 26; 43(2):219-24. PubMed ID: 7554318 [Abstract] [Full Text] [Related]
20. Endometrial and vaginal response to three different oestrogen preparations administered by the transdermal and oral routes. Johannisson E, Landgren BM, Diczfalusy E. Maturitas; 1988 Oct 26; 10(3):181-92. PubMed ID: 3185292 [Abstract] [Full Text] [Related] Page: [Next] [New Search]